RMI Investments

RMI Investments S.a.r.l. is a Luxembourg-based venture capital vehicle and a subsidiary of RusnanoMedInvest (RMI LLC), a major life sciences investment firm founded by the Russian state corporation RUSNANO. The firm specializes in investing in innovative biotechnology, pharmaceutical, and medical technology companies globally, with a significant focus on the U.S. market. RMI Investments has been a prominent shareholder in several clinical-stage biopharmaceutical companies, including Syndax Pharmaceuticals, Clearside Biomedical, and binx health. Historically, the company has collaborated with international venture capital partners like Domain Associates to facilitate the development and commercialization of advanced medical technologies. Its investment portfolio targets high-impact solutions in therapeutic areas such as oncology, ophthalmology, and molecular diagnostics.